Takeda Agreement definition

Takeda Agreement means the Contract identified as the Takeda Agreement on Schedule 1.1(c).

Takeda Agreement means the April 8, 1994 License Agreement between Takeda Chemical Industries, Ltd. and IMMUNOGEN.

Takeda Agreement means that certain Amended and Restated Agreement dated as of October 21, 2019, by and between Finch Therapeutics, Inc., a Delaware corporation, and Millennium Pharmaceuticals, Inc., a Delaware corporation having its principal office at 40 Landsdowne Street, Cambridge, Massachusetts 02139, USA.

Examples of Takeda Agreement in a sentence

• We refer to the amended and restated development and license agreement, as amended, as the Takeda Agreement.

• On March 4, 2019, we entered into the fourth amendment to the Takeda Agreement, or the Takeda Amendment.

• In December 2019, the Company partitioned the Amended Takeda Agreement into two separate agreements: (i) an amended and restated license agreement for PDK (the “PDK Agreement”), and (ii) an amended and restated license agreement for RAF (the “Millennium RAF Agreement”).

• Pursuant to the Takeda Commercial Supply Agreement, Takeda has agreed to supply the Company and the Company has agreed to obtain from Takeda certain quantities of relugolix drug substance according to agreed-upon quality specifications and in order to commercialize relugolix in accordance with the Takeda Agreement.

• DuvelisibPursuant to the Takeda Agreement, prior to March 4, 2019, we were obligated to share equally with Takeda all revenue arising from certain qualifying transactions for duvelisib, including the Secura Bio Agreement, subject to certain exceptions including revenue we receive as reimbursement for duvelisib research and development expenses.

• Under this agreement, the Company no longer has research obligations, but licenses granted to Biogen with respect to the research collaboration under the Biogen OCA (other than the licenses transferred to Takeda Oncology under the Takeda Agreement) remain in effect.

• In connection with the execution of the Amended Takeda Agreement, the Company paid an upfront fee and may be required to make up to $9.2 million in pre-commercialization milestone payments depending on its development of PDK1 inhibitors and tiered royalty payments based on percentages of net sales, if any, beginning in the mid-single-digits and not to exceed the low-teens.

• Under the terms of the Amended Takeda Agreement, Takeda had exclusive rights to develop and commercialize Feraheme as a therapeutic agent in certain agreed-upon territories outside of the U.S. We are in the process of regaining all worldwide development and commercialization rights for Feraheme following the transfer of the outstanding marketing authorizations to us.

• We refer to the amended and restated development and license agreement, as amended, as the Takeda Agreement.DuvelisibPursuant to the Takeda Agreement, prior to March 4, 2019, we were obligated to share equally with Takeda all revenue arising from certain qualifying transactions for duvelisib, including the Secura Bio Agreement, subject to certain exceptions including revenue we receive as reimbursement for duvelisib research and development expenses.

• Under this agreement, the Company no longer has research obligations, but licenses granted to Biogen with respect to the research collaboration under the Biogen OCA (other than the licenses transferred to Takeda under the Takeda Agreement) remain in effect.

More Definitions of Takeda Agreement

Takeda Agreement means that certain Agreement dated September 30, 2003 (and as subsequently amended by the parties thereto) by and between Takeda Pharmaceutical Company Limited (previously known as Takeda Chemical Industries, Ltd.), and Target (which Agreement was originally entered into by Takeda Chemical Industries, Ltd. and between Peninsula Pharmaceuticals, Inc., the predecessor in interest to Target).

Takeda Agreement means that certain Amended and Restated Agreement dated as of October 21, 2019, by and between Fxxxx Therapeutics, Inc., a Delaware corporation, and Millennium Pharmaceuticals, Inc., a Delaware corporation having its principal office at 40 Xxxxxxxxxx Xxxxxx, Xxxxxxxxx, Xxxxxxxxxxxxx 00000, XXX.

Takeda Agreement means that certain Royalty, License and Termination Agreement Relating to License and Collaboration Agreement dated January 6, 2017, dated as of March 2, 2021, by and between Seller and Takeda, and as may be further amended pursuant to Section 5.6(a). “Takeda Confidential Information” means, collectively, the Takeda Consent, the Ancillary Agreements, the Takeda Agreement and any and all Confidential Information (as defined in the Takeda Agreement) disclosed by or on behalf of Takeda under the Takeda Agreement, including the Quarterly Reports, any notices or correspondence delivered to Seller by Takeda pursuant to Section 7.9 of the Takeda Agreement and any audit reports disclosed to Seller pursuant to Section 7.10 of the Takeda Agreement.